Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Authors :
Pfizer; Neelima Vidula, Principal Investigator
-
Source:
Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial
تفاصيل العنوان
-
Source:
Prospective and Multicentric Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With
تفاصيل العنوان
-
Authors :
Tesaro, Inc.; Marina Frimer, Principle Investigator
-
Source:
Trial of Maintenance With Niraparib in Patients With Stage III, Stage IV or Platinum-sensitive Recurrent Uterine Serous CarcinomaPennington KP, Walsh T, Lee M, Pennil C, Novetsky AP, Agnew KJ,
تفاصيل العنوان
-
Source:
Olaparib for Pulmonary Arterial Hypertension: a Multicenter Clinical Trial
تفاصيل العنوان
-
Source:
Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer
تفاصيل العنوان
-
Authors :
Steeve Provencher, Professor
-
Source:
Olaparib for Pulmonary Arterial Hypertension: a Pilot Clinical StudyChen PI, Cao A, Miyagawa K, Tojais NF, Hennigs JK, Li CG, Sweeney NM, Inglis AS, Wang L, Li D, Ye M, Feldman BJ, Rabinovitch
تفاصيل العنوان
